Lucid Diagnostics Ownership | Who Owns Lucid Diagnostics?


OverviewForecastRevenueFinancialsChartTranscripts

Lucid Diagnostics Ownership Summary


Lucid Diagnostics is owned by 19.13% institutional investors, 34.45% insiders, and 46.42% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 3.66% of LUCD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.06% of its assets in Lucid Diagnostics shares.

LUCD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLucid Diagnostics19.13%34.45%46.42%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryMedical Device Stocks52.08%10.61%37.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de3.62M3.66%$4.16M
Masters capital management2.73M2.76%$3.14M
Vanguard group560.91K1.11%$459.39K
Luminus management794.83K0.80%$914.05K
Alyeska investment group738.28K0.75%$849.02K
Geode capital management279.50K0.55%$228.85K
Lido advisors383.08K0.39%$440.54K
First manhattan co. llc.323.45K0.33%$371.97K
Xml financial178.79K0.18%$205.61K
Goldman sachs group63.58K0.13%$52.05K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Luminus management794.83K0.24%$914.05K
Masters capital management2.73M0.12%$3.14M
Xml financial178.79K0.02%$205.61K
Sargent investment group54.03K0.01%$53.48K
Byrne asset management11.00K0.01%$9.56K
Sunbelt securities84.00K0.01%$68.77K
Nantahala capital management94.54K0.00%$108.72K
Traphagen investment advisors29.30K0.00%$33.69K
Alyeska investment group738.28K0.00%$849.02K
Lido advisors383.08K0.00%$440.54K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de3.62M0.00%3.59M
Luminus management794.83K0.24%338.19K
First manhattan co. llc.323.45K0.00%310.85K
Geode capital management279.50K-65.96K
Goldman sachs group63.58K-63.58K

Top Sellers

HolderShares% AssetsChange
Alyeska investment group738.28K0.00%-1.15M
Sunbelt securities84.00K0.01%-300.00K
Levin capital strategies---66.53K
Verition fund management---39.71K
Geneos wealth management---29.55K

New Positions

HolderShares% AssetsChangeValue
Goldman sachs group63.58K-63.58K$52.05K
Mml investors services50.00K0.00%50.00K$58.00K
Intech investment management36.35K0.00%36.35K$41.81K
Graham capital management29.95K0.00%29.95K$34.44K
Traphagen investment advisors29.30K0.00%29.30K$33.69K

Sold Out

HolderChange
Thompson investment management-1.00
Newedge advisors-2.00
Ubs group-2.00
Newbridge financial services group-50.00
Qube research-103.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20257052.17%18,934,126111.46%1911.29%5066.67%6-25.00%
Mar 31, 20254746.88%9,415,056184.29%1331.66%3163.16%8-
Dec 31, 20243114.81%3,227,77831.56%627.01%1880.00%814.29%
Sep 30, 202427-15.63%2,453,40423.06%424.83%10-33.33%7-22.22%
Jun 30, 20243214.29%1,993,585-3.75%418.00%15-25.00%950.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.10M2.06%-45.81K
iShares Russell 2000 ETF1.47M1.36%-27.93K
Vanguard Institutional Extnd Mkt Idx Tr865.50K0.85%-394.38K
Fidelity Small Cap Index685.13K0.67%685.13K
Fidelity Extended Market Index366.09K0.34%240.38K
Vanguard Russell 2000 ETF326.38K0.32%-25.94K
iShares Russell 2000 Value ETF340.55K0.31%253.00
iShares Russell 2000 Growth ETF257.50K0.24%-
State St Russell Sm Cap® Indx SL Cl I242.40K0.22%-
Schwab Small Cap Index174.87K0.17%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 20, 2025Matheis Dennis-Buy$101.84K
May 20, 2025Matheis Dennis-Buy$242.29K
May 21, 2025Matheis Dennis-Buy$171.52K
May 22, 2025Matheis Dennis-Buy$43.79K
May 21, 2025Matheis Dennis-Buy$171.52K

Insider Transactions Trends


DateBuySell
2025 Q31-
2025 Q26-
2025 Q1--
2024 Q2--
2024 Q1--

LUCD Ownership FAQ


Who Owns Lucid Diagnostics?

Lucid Diagnostics shareholders are primarily institutional investors at 19.13%, followed by 34.45% insiders and 46.42% retail investors. The average institutional ownership in Lucid Diagnostics's industry, Medical Device Stocks, is 52.08%, which Lucid Diagnostics falls below.

Who owns the most shares of Lucid Diagnostics?

Lucid Diagnostics’s largest shareholders are Blackrock funding, inc. /de (3.62M shares, 3.66%), Masters capital management (2.73M shares, 2.76%), and Vanguard group (560.92K shares, 1.11%). Together, they hold 7.52% of Lucid Diagnostics’s total shares outstanding.

Does Blackrock own Lucid Diagnostics?

BlackRock is not among the top 10 institutional shareholders of Lucid Diagnostics.

Who is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested?

Luminus management is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.24% of its assets in 794.83K Lucid Diagnostics shares, valued at 914.05K$.

Who is the top mutual fund holder of Lucid Diagnostics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lucid Diagnostics shares, with 2.06% of its total shares outstanding invested in 2.1M Lucid Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools